We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.56B
AUM Growth
-$179M
Cap. Flow
-$104M
Cap. Flow %
-1.58%
Top 10 Hldgs %
11.86%
Holding
354
New
15
Increased
110
Reduced
195
Closed
8

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$26.8M
2
BIG
Big Lots, Inc.
BIG
+$24.1M
3
HMN icon
Horace Mann Educators
HMN
+$20.2M
4
DG icon
Dollar General
DG
+$19.9M
5
DHX icon
DHI Group
DHX
+$17.3M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 16.27%
3 Healthcare 13.91%
4 Industrials 12.55%
5 Consumer Discretionary 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OII icon
176
Oceaneering
OII
$5.25B
$12.2M 0.19%
262,494
+59,756
+29% +$3.14M
MTB icon
177
M&T Bank
MTB
$36.2B
$12.1M 0.19%
97,237
-1,425
-1% -$175K
JLL icon
178
Jones Lang LaSalle
JLL
$15.1B
$12M 0.18%
69,967
+820
+1% +$138K
CMD
179
DELISTED
Cantel Medical Corporation
CMD
$11.9M 0.18%
220,938
-121,222
-35% -$5.9M
EV
180
DELISTED
Eaton Vance Corp.
EV
$11M 0.17%
281,445
+6,656
+2% +$274K
VAR
181
DELISTED
Varian Medical Systems, Inc.
VAR
$10.9M 0.17%
147,977
-667
-0.4% -$52.2K
GEOS icon
182
Geospace Technologies
GEOS
$91.6M
$10.8M 0.17%
470,298
-9,402
-2% -$196K
NDSN icon
183
Nordson
NDSN
$16.5B
$10.8M 0.17%
138,919
+3,450
+3% +$278K
BOKF icon
184
BOK Financial
BOKF
$8.64B
$10.7M 0.16%
154,262
+3,274
+2% +$214K
DAR icon
185
Darling Ingredients
DAR
$9.93B
$10.5M 0.16%
717,395
-21,370
-3% -$315K
WAB icon
186
Wabtec
WAB
$51.1B
$10.4M 0.16%
110,469
-20,582
-16% -$2.02M
EWBC icon
187
East-West Bancorp
EWBC
$17.9B
$10.2M 0.16%
227,007
+4,878
+2% +$209K
MLNX
188
DELISTED
Mellanox Technologies, Ltd.
MLNX
$10M 0.15%
205,757
-504,397
-71% -$24.5M
SEIC icon
189
SEI Investments
SEIC
$11.9B
$9.95M 0.15%
203,016
+4,029
+2% +$189K
NGS icon
190
Natural Gas Services Group
NGS
$470M
$9.63M 0.15%
422,167
-10,406
-2% -$243K
TMP icon
191
Tompkins Financial
TMP
$1.45B
$9.44M 0.14%
175,766
-2,670
-1% -$141K
TFC icon
192
Truist Financial
TFC
$63.2B
$9.37M 0.14%
232,500
-285,400
-55% -$11.3M
IFF icon
193
International Flavors & Fragrances
IFF
$19.4B
$9.24M 0.14%
84,519
+3,317
+4% +$383K
COO icon
194
Cooper Companies
COO
$13.7B
$9.23M 0.14%
207,464
+5,288
+3% +$238K
USPH icon
195
US Physical Therapy
USPH
$1.14B
$9M 0.14%
+164,334
New +$8.14M
STI
196
DELISTED
SunTrust Banks, Inc.
STI
$8.99M 0.14%
208,940
+194,490
+1,346% +$8.27M
SBNY
197
DELISTED
Signature Bank
SBNY
$8.97M 0.14%
61,307
+784
+1% +$109K
BRO icon
198
Brown & Brown
BRO
$22.9B
$8.95M 0.14%
544,434
+25,646
+5% +$419K
FDS icon
199
Factset
FDS
$9.05B
$8.84M 0.13%
54,421
+10
+0% +$1.63K
ES icon
200
Eversource Energy
ES
$28.2B
$8.64M 0.13%
190,335
+16,410
+9% +$796K

Similar funds

Boston Trust Walden's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Trust Walden held 354 positions worth $6.56B, down 2.7% from $6.74B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boston Trust Walden's Q2 2015 filing shows 15 new, 110 increased, 195 reduced and 8 closed positions. Its largest new stake was Masimo: 749,049 shares worth $29M. The largest sale was Blackbaud, an estimated $30.3M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q2 2015 buy was Masimo: 749,049 shares worth $29M.
  • Boston Trust Walden added most to Merck in Q2 2015, an estimated $16.8M increase.
  • Boston Trust Walden's biggest Q2 2015 reduction was Mellanox Technologies, Ltd., cutting an estimated $24.5M.
  • Boston Trust Walden fully exited Blackbaud in Q2 2015, selling an estimated $30.3M.
  • Boston Trust Walden's ten largest holdings make up 12% of its $6.56B portfolio in Q2 2015.
  • Boston Trust Walden opened 15 new positions and closed 8 in Q2 2015.
  • Boston Trust Walden's portfolio value fell 2.7% quarter-over-quarter to $6.56B.

Based on Boston Trust Walden's 13F filing for Q2 2015, filed 17 Jul 2015.